These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 30635020)
1. Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction. Pels A; Jakobsen JC; Ganzevoort W; Naaktgeboren CA; Onland W; van Wassenaer-Leemhuis AG; Gluud C Trials; 2019 Jan; 20(1):42. PubMed ID: 30635020 [TBL] [Abstract][Full Text] [Related]
2. Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial. Pels A; Derks J; Elvan-Taspinar A; van Drongelen J; de Boer M; Duvekot H; van Laar J; van Eyck J; Al-Nasiry S; Sueters M; Post M; Onland W; van Wassenaer-Leemhuis A; Naaktgeboren C; Jakobsen JC; Gluud C; Duijnhoven RG; Lely T; Gordijn S; Ganzevoort W; JAMA Netw Open; 2020 Jun; 3(6):e205323. PubMed ID: 32585017 [TBL] [Abstract][Full Text] [Related]
3. STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials. Pels A; Kenny LC; Alfirevic Z; Baker PN; von Dadelszen P; Gluud C; Kariya CT; Mol BW; Papageorghiou AT; van Wassenaer-Leemhuis AG; Ganzevoort W; Groom KM; BMC Pregnancy Childbirth; 2017 Dec; 17(1):440. PubMed ID: 29282009 [TBL] [Abstract][Full Text] [Related]
10. Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction. Sharp A; Cornforth C; Jackson R; Harrold J; Turner MA; Kenny L; Baker PN; Johnstone ED; Khalil A; von Dadelszen P; Papageorghiou AT; Alfirevic Z Lancet Child Adolesc Health; 2019 Mar; 3(3):e2-e3. PubMed ID: 30704877 [No Abstract] [Full Text] [Related]
11. Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial. Shehata NAA; Ali HAA; Fahim AS; Katta MA; Hussein GK J Matern Fetal Neonatal Med; 2020 May; 33(10):1631-1637. PubMed ID: 30345864 [No Abstract] [Full Text] [Related]
12. Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations. von Dadelszen P; Audibert F; Bujold E; Bone JN; Sandhu A; Li J; Kariya C; Chung Y; Lee T; Au K; Skoll MA; Vidler M; Magee LA; Piedboeuf B; Baker PN; Lalji S; Lim KI BMC Res Notes; 2022 Jul; 15(1):244. PubMed ID: 35799272 [TBL] [Abstract][Full Text] [Related]
13. Perinatal deaths after sildenafil treatment of fetal growth restriction raise the issue of safety in randomised clinical trials. Lombardi N; Crescioli G; Bettiol A; Ravaldi C; Vannacci A Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):437-438. PubMed ID: 30847998 [No Abstract] [Full Text] [Related]
14. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction. Groom KM; David AL Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321 [TBL] [Abstract][Full Text] [Related]
15. Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices. Trapani A; Gonçalves LF; Trapani TF; Franco MJ; Galluzzo RN; Pires MM Ultrasound Obstet Gynecol; 2016 Jul; 48(1):61-5. PubMed ID: 26279411 [TBL] [Abstract][Full Text] [Related]
16. Neonatal pulmonary hypertension after severe early-onset fetal growth restriction: post hoc reflections on the Dutch STRIDER study. Pels A; Onland W; Berger RMF; van Heijst AFJ; Lopriore E; Reiss IKM; Limpens J; Gordijn SJ; Ganzevoort W Eur J Pediatr; 2022 Apr; 181(4):1709-1718. PubMed ID: 35018508 [TBL] [Abstract][Full Text] [Related]
17. Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER Consortium. Groom KM; Ganzevoort W; Alfirevic Z; Lim K; Papageorghiou AT; Ultrasound Obstet Gynecol; 2018 Sep; 52(3):295-296. PubMed ID: 30079989 [No Abstract] [Full Text] [Related]
18. TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial. Umekawa T; Maki S; Kubo M; Tanaka H; Nii M; Tanaka K; Osato K; Kamimoto Y; Tamaru S; Ogura T; Nishimura Y; Kodera M; Minamide C; Nishikawa M; Endoh M; Kimura T; Kotani T; Nakamura M; Sekizawa A; Ikeda T; BMJ Open; 2018 Oct; 8(10):e020948. PubMed ID: 30381311 [TBL] [Abstract][Full Text] [Related]
19. Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: a meta-analysis. Chen J; Gong X; Chen P; Luo K; Zhang X BMC Pregnancy Childbirth; 2016 Aug; 16():225. PubMed ID: 27528012 [TBL] [Abstract][Full Text] [Related]
20. Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes. Bond DM; Gordon A; Hyett J; de Vries B; Carberry AE; Morris J Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009433. PubMed ID: 26599471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]